Xiang Fu
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Metabolic profile analysis of key pentacyclic triterpenoid saponins from Abrus cantoniensis Hance and the interaction with hepatoprotective pharmacodynamic targets.
Journal: Journal of pharmaceutical and biomedical analysis
Published: April 29, 2026
The impact of sports participation on the social integration of China's migrant population: a serial mediation model of life satisfaction and subjective well-being.
Journal: Frontiers in sports and active living
Published: March 07, 2026
The Latest Therapeutic Targets and New Drug Research of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Clinical pharmacology and therapeutics
Published: February 13, 2026
Rhodium(II)-incorporated metal-organic framework catalyst combined with flow chemistry for efficient carbene-mediated three-component reactions.
Journal: Organic & biomolecular chemistry
Published: December 12, 2025
Correction to "Multicomponent Reaction-Enabled Semisynthesis of Taxanes Yields an Analogue with Reduced Chemotherapy-Induced Neuropathy".
Journal: JACS Au
Published: November 25, 2025
The benefit and risk of adding immunotherapy to chemoradiotherapy as the first-line treatment for limited-stage small cell lung cancer: a meta-analysis of randomized controlled trials.
Journal: World journal of surgical oncology
Published: June 19, 2025
Three-Component 1,3-Difunctionalization of Carbonyl Ylides with Water and Azadienes for the Synthesis of Dihydroisobenzofurans.
Journal: Organic letters
Published: March 27, 2025
Post-marketing safety surveillance of Amivantamab: a real world study based on the FDA adverse event reporting system.
Journal: Expert opinion on drug safety
Published: February 26, 2025
Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA+ neutrophil prognostic model.
Journal: Biology direct
Published: December 26, 2024
The benefit and risk of addition of chemotherapy to EGFR tyrosine kinase inhibitors for EGFR-positive non-small cell lung cancer patients with brain metastases: a meta-analysis based on randomized controlled trials.
Journal: Frontiers in oncology
Published: June 13, 2024
Last Updated: 09/26/2026